HIV disease: therapy, related systemic and oral conditions--an update.
Garfunkel
A A
AA
Hadassah, Hebrew University, Jerusalem, Israel.
Glick
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D016049:Didanosine / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009059:Mouth Diseases / Q000150:complications* / Q000188:drug therapy; D009181:Mycoses / Q000150:complications / Q000188:drug therapy; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy; D014777:Virus Diseases / Q000150:complications / Q000188:drug therapy; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine